Clinical Trial 45088

Pinellas Park, FL 33782


Summary:

Efficacy and safety of GSK3196165 versus placebo and tofacitinib in participants with moderately to severely active rheumatoid arthritis who have an inadequate response to conventional synthetic/biologic DMARDs.


Qualified Participants Must:

• Be Male or Female ages 18 and over
• Be diagnosed with Rheumatoid Arthritis


Qualified Participants May Receive:

Study related care and compensation may be provided


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.